Does XELODA Cause Malignant neoplasm progression? 45 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Malignant neoplasm progression have been filed in association with XELODA. This represents 4.2% of all adverse event reports for XELODA.
45
Reports of Malignant neoplasm progression with XELODA
4.2%
of all XELODA reports
8
Deaths
7
Hospitalizations
How Dangerous Is Malignant neoplasm progression From XELODA?
Of the 45 reports, 8 (17.8%) resulted in death, 7 (15.6%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for XELODA. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does XELODA Cause?
Death (303)
Diarrhoea (141)
Disease progression (137)
Nausea (81)
Vomiting (71)
Palmar-plantar erythrodysaesthesia syndrome (70)
Fatigue (50)
Pain (37)
Asthenia (36)
Decreased appetite (32)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)